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Background: Development of a method for long-term labeling of cells is critical to elucidate transplanted cell fate
and migration as well as the contribution to tissue regeneration. Silica nanoparticles have been recently developed
and demonstrated to be biocompatible with a high labeling capacity. Thus, our study was designed to assess the
suitability of silica nanoparticles for labeling canine mesenchymal stem cells (MSCs) and the fluorescence afficiency
in highly autofluorescent tissue.
Results: We examined the effect of silica nanoparticle labeling on stem cell morphology, viability and
differentiation as compared with those of unlabeled control cells. After 4 h of incubation with silica nanoparticles,
they were internalized by canine MSCs without a change in the morphology of cells compared with that of control
cells. The viability and proliferation of MSCs labeled with silica nanoparticles were evaluated by a WST-1 assay and
trypan blue exclusion. No effects on cell viability were observed, and the proliferation of canine MSCs was not
inhibited during culture with silica nanoparticles. Furthermore, adipogenic and osteogenic differentiation of silica
nanoparticle-labeled canine MSCs was at a similar level compared with that of unlabeled cells, indicating that silica
nanoparticle labeling did not alter the differentiation capacity of canine MSCs. Silica nanoparticle-labeled canine
MSCs were injected into the kidneys of BALB/c mice after celiotomy, and then the mice were sacrificed after 2 or
3 weeks. The localization of injected MSCs was closely examined in highly autofluorescent renal tissues.
Histologically, canine MSCs were uniformly and completely labeled with silica nanoparticles, and were
unambiguously imaged in histological sections.
Conclusions: The results of the current study showed that silica nanoparticles are useful as an effective labeling
marker for MSCs, which can elucidate the distribution and fate of transplanted MSCs.Background
Adult mesenchymal stem cells (MSCs) are a cellular tool
with promising application in both veterinary and
human medicine. MSCs have the potential to repair tis-
sues [1-4] and improve the function of damaged organs.
Thus, many clinical trials are in progress to evaluate the
therapeutic potentials of MSCs for treating renal failure,
diabetes mellitus and heart failure [5-9].* Correspondence: hyyoun@snu.ac.kr
1Department of Veterinary Internal Medicine, College of Veterinary Medicine,
Seoul National University, Seoul 151-742, Korea
Full list of author information is available at the end of the article
© 2012 Han et al.; licensee BioMed Central Ltd
Commons Attribution License (http://creativec
reproduction in any medium, provided the orTracking of stem cells is essential for evaluating cell re-
placement and therapeutic strategies [10]. In addition,
long-term labeling of stem cells is critical to elucidate
their fate, migration, and contribution to regenerating
tissues. Conventional labeling methods used in cell and
developmental biology include bromodeoxyuridine,
chloromethyl dye, fluorescent in situ hybridization, 4'-6-
diamidino-2-phenylindole (DAPI), and green fluorescent
protein (GFP). However, these conventional labeling
methods have limitations for use in labeling of stem cells
[9,11]. Labeling methods using chemicals may affect stem
cell functions [7], and most fail to fluoresce for a long
period owing to photobleaching [12]. Moreover,. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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fluorescence to identify transplanted cells in tissue sec-
tions, and these protocols may produce false-positive
results [7,13].
To overcome these issues, different kinds of nanoma-
terials have been created to track stem cells. Silica is a
suitable nanomaterial for bifunctional or multifunctional
cellular labeling because it is biocompatible, resistant to
biodegradation in cellular environments and can be eas-
ily functionalized for bioconjugation [14,15]. Nanoparticles
are coated with a shell of silica to avoid potential toxic
effects. The silica shell contains luminescent organic dyes
(ODs) such as rhodamine B isothiocyanate (RITC) or
fluorescein isothiocyanate, resulting in a fluorescent and
magnetic nanomaterial. In particular, incorporated ODs
are more available than commercial OD products owing
to their resistance to photobleaching. Because silica is
stable under strong basic and acidic conditions, the fluor-
escent properties also remain stable [16]. In addition,
many approaches involve endocytosis that contributes to
higher uptake and retention of silica nanoparticles in
MSCs [14,17]. However, no study has investigated the
effects of silica nanoparticles as a labeling reagent for
MSCs.
Therefore, we examined whether silica nanoparticles
affected cell viability and the differentiation potential of
MSCs, and evaluated the fluorescence efficiency in
highly autofluorescent renal tissues.Figure 1 Optimal concentration and incubation time of silica nanopa
than 4 h with 200 or 400 μg/ml silica nanoparticles, which yielded visible f
100 μg/ml. The majority of cells showed cytoplasmic fluorescence after 4 hResults
MSCs internalize silica nanoparticles and maintain typical
MSC morphology
As shown in Figure 1, silica nanoparticles were taken up
by cells, and concentrated fluorescence was observed in-
side canine MSCs with increasing incubation time. After
4 h of incubation, silica nanoparticles were visible in the
cytoplasm of MSCs at labeling concentrations of 200
and 400 μg/ml. Using sufficient concentrations, silica
nanoparticles were completely internalized by MSCs
within 4 h (Figure 1). Thus, we used 200 μg/ml silica
nanoparticles for subsequent experiments.
The morphology of canine umbilical cord blood (UCB)
MSCs and adipose tissue-derived (AT) MSCs was typical
with fibroblastoid and spindle shapes, and the cells
remained adherent (Figure 2b, h). After 4 h of incubation,
silica nanoparticles were internalized by canine ATMSCs
and UCBMSCs (Figure 2d, j) without altering the morph-
ology of cells (Figure 2e, i), compared with that of control
cells. The overlay (merged) images revealed co-
localization of fluorescent cells in paired differential
interference contrast (DIC) images (Figure 2c, f, i, l).
Silica nanoparticles do not affect canine MSC viability or
proliferation
To evaluate potential cytotoxicity of silica nanoparti-
cles in canine MSCs, a WST-1 assay, which measures
cell viability relative to the metabolic activity, wasrticles for labeling of MSCs. UCBMSCs were incubated for more
luorescent signals. However, no effective fluorescence occurred at
of incubation. Magnification, ×400.
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cles for 24 h. Figure 3a shows the effect of silica nano-
particles on the viability and metabolic activity of
canine MSCs. The percentage of viable canine MSCs
was not significantly different in the presence of in-
creasing concentrations of silica nanoparticles, and
was not significantly different from that of the control
(P > 0.05, analysis of variance).
Because the WST-1 assay does not distinguish be-
tween the induction of cell death and the inhibition
of proliferation, cell viability was measured by count-
ing cells using trypan blue exclusion following expos-
ure of the cells to silica nanoparticles. Silica
nanoparticles at concentrations of 100, 200, 300 and
400 μg/ml had no significant effect on the cell viabil-
ity of canine MSCs and their proliferation (Figure 3b,
c). This result indicates that the presence of nanopar-
ticles did not interfere with the viability or prolifera-
tion of canine MSCs.Figure 2 Silica nanoparticles are internalized without affecting cell m
incubation with canine ATMSCs and UCBMSCs (c, h). Labeled canine MSCs
shapes. No notable differences in morphology were observed compared wSilica nanoparticles do not inhibit the differentiation
potential of canine MSCs
To assess the effect of silica nanoparticles on canine
MSC differentiation, silica nanoparticle-labeled canine
ATMSCs and UCBMSCs were cultured for 3 weeks
under adipogenic and osteogenic induction conditions.
Strong staining of Oil Red O or Alizarin Red S can inter-
fere with the red fluorescence even in fluoroscope, we
induced respectively for examination of Oil Red O or
Alizarin Red S staining and red fluorescence.
Adipogenic induction of canine MSCs labeled with sil-
ica nanoparticles resulted in expanded cell morphology.
Staining with intracellular Oil Red O, a commonly used
lipid dye (Figure 4), indicated that lipids had accumu-
lated within the cells in small vacuoles, which appeared
as droplets in canine ATMSCs and UCBMSCs. Adipo-
genic differentiation of silica nanoparticle-labeled canine
ATMSCs and UCBMSCs was at a similar level as that of
unlabeled cells. However, lipid accumulation inorphology. Silica nanoparticles were internalized after 4 h of
(c, d) spread well on the dish, and showed fibroblastoid and spindle
ith that of unlabeled canine MSCs (a, b). Magnification, ×400.
Figure 3 Determination of cell viability and proliferation in the presence of silica nanoparticles for labeling of canine MSCs. (a) Canine
MSCs were incubated without (control) or with 100, 200, 300, or 400 μg/ml silica nanoparticles (NP) for 24 h, and then cell viability was measured
by a WST-1 assay. No significant differences in metabolic activity were observed compared with that of the control during culture with silica
nanoparticles. Each concentration was assayed in triplicate. (b, c) Trypan blue exclusion showed that the proliferation of canine MSCs was not
inhibited. No significant differences in cell number were observed compared with that of the control during culture with silica nanoparticles.
Each concentration was evaluated in triplicate. Data are the means ± standard deviations (P > 0.05, analysis of variance).
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the canine UCBMSC characteristics [18]. When MSCs
underwent osteogenic differentiation, they proliferated
rapidly and formed tightly packed colonies. Cells were
then stained with Alizarin Red S to assess mineralization
(Figure 5). Osteogenic differentiation of canine ATMSCs
and UCBMSCs labeled with nanoparticles occurred at a
similar level as that of unlabeled cells. Using a fluoro-
scope, differentiated MSCs labeled with silica nanoparti-
cles showed cytoplasmic retention of fluorescence
(Figures 4 and 5). These results show that adipogenic
and osteogenic differentiation of canine MSCs was not
inhibited by silica nanoparticles.
MSCs labeled with silica nanoparticles are unambiguously
detected in renal tissue
Approximately 2 × 105 MSCs labeled with silica nano-
particles were injected into a mouse kidney afterceliotomy. All treated mice remained healthy and
gained weight normally. Mice were sacrificed after 2 or
3 weeks, and the gross appearance of the kidneys was
normal except for mild hemorrhaging in the renal cap-
sule at the injection site. Histological sections (4 μm
thick) of renal tissue were prepared and examined for
fluorescence. The renal cortex and medullary region
were necrotic owing to the injection, which caused
mechanical injury (Figure 6c). Silica nanoparticle-
labeled MSCs were found predominantly in the corti-
comedullary and medullary regions that mainly consist
of the proximal and distal tubules and the loop of
Henle (Figure 6a). Co-localization of fluorescent silica
nanoparticles and DAPI nuclear staining was observed
(Figure 6b). This result indicates that silica
nanoparticle-labeled MSCs were easily tracked, and
silica nanoparticle fluorescence remained in canine
MSCs for more than 3 weeks.
Figure 4 Comparison of adipogenic differentiation between labeled and unlabeled canine MSCs. UCBMSCs and ATMSCs were cultured in
adipogenic differentiation medium for 21 days. Cells were then stained with oil red O. Red lipid droplets were visible in UCBMSCs and ATMSCs,
indicating adipogenic differentiation. Adipogenic differentiation was not inhibited by silica nanoparticle labeling as compared with that of
unlabeled cells. Magnification, ×200.
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Our study demonstrated that canine MSCs can be ef-
fectively labeled by incubation with silica nanoparticles
without impairing the cell morphology, viability or meta-
bolic activity. In addition, silica nanoparticle-labeled
MSCs exhibited a similar level of differentiation into adi-
pocytes and osteocytes compared with that of unlabeled
MSCs. Moreover, silica nanoparticle-labeled MSCs were
uniformly visualized in the kidney at more than 3 weeks
after transplantation.Figure 5 Comparison of osteogenic differentiation between labeled a
osteogenic differentiation medium for 21 days. Cells were then stained wit
osteogenic induction. Osteogenic differentiation was not inhibited by silica
Magnification, ×200.These results demonstrate obvious benefits compared
with other nanomaterials. Recently developed quantum
dots show strong luminance and high photostability
compared with those of conventional organic fluoro-
phores [19]. However, the toxic potential of cadmium
nanoparticles has remained a concern [20]. Boddington
et al. reported [21] that the iron oxide nanoparticle feru-
carbotran may impair MSC differentiation, which hin-
ders their potential use as fluorescence tracers for stem
cells. In contrast, the toxicological effects of amorphousnd unlabeled canine MSCs. UCBMSCs and ATMSCs were cultured in
h alizarin red S. Red calcium deposition was observed following
nanoparticle labeling as compared with that in unlabeled cells.
Figure 6 Tracking of nanoparticle-labeled ATMSCs in the kidney. (a) Transplanted silica nanoparticle-labeled ATMSCs were detected at the
cortical medullary junction and in the medullary region at 2 and 3 weeks after injection. Fluorescent cells were not observed in the cortical
region. Many fluorescent cells were unambiguously detected (arrows) in the corticomedullary and medullary regions. Cortical region:
Magnification, ×100; corticomedullary and medullary region: Magnification, ×200. (b) ATMSC-injected kidneys were stained with DAPI and
examined by confocal laser scanning microscopy. Arrowhead indicates co-localization of fluorescent silica nanoparticles and DAPI nuclear
staining. Magnification, ×200. (c) The injection site was clearly observed in H&E-stained sections. Hemorrhages (black arrow) were detected and
mild necrosis (black arrow head) was observed near the injection site. Magnification, ×100. The hemorrhagic region in (c) was magnified to show
more detail. Magnification, ×400.
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form has been found to be less toxic in animal experi-
ments than that of other nanomaterials. Although some
studies suggest that inhaling of materials such as col-
loidal silica by mice induces dose and size-dependent
pulmonary effects [22,23], silica nanoparticles demon-
strate no apparent toxicity in mice when injected via the
tail vein [24]. Similarly, the safety of silica nanoparticles
was confirmed in our study. The viability of unlabeled
and silica nanoparticles-labeled cells, as measured by the
WST-1 assay and trypan blue exclusion, was not signifi-
cantly different, suggesting that silica nanoparticles are
cytocompatible and do not induce cell death. Moreover,the differentiation capacity of MSCs toward multiple cell
lineages was not affected by silica nanoparticle labeling.
Labeled MSCs showed similar elaboration of mineralized
matrix and accumulation of lipid droplets, compared
with those of unlabeled MSCs during osteogenic and
adipogenic differentiation, respectively.
We also demonstrated that silica nanoparticle-labeled
MSCs can be histologically located in the kidney and
tracked. Endocytosed silica nanoparticles persisted in
expanded canine MSCs for up to 3 weeks. This 3 week
period was sufficient for transplanted MSCs to migrate
and differentiate in the host tissue. Furthermore, the
fluorescence was not weakened until 3 weeks after
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oxide nanoparticles show significant decreases in fluor-
escence after 1 month [25]. Such long-term labeling of
stem cells will be beneficial for elucidating the relative
contributions of native and engineered tissues to mor-
phogenesis. Furthermore, silica nanoparticles can be
imaged in renal tissue without additional staining. The
kidney is a highly autofluorescent tissue owing to its ex-
tremely high metabolic rate, accumulation of flavins and
lipofuscins, and vascularization [26]. Tissue autofluores-
cence has long posed a problem for studies of immuno-
fluorescence labeling, and particularly for direct staining.
Because it has been difficult to reduce autofluorescence
in tissues, efficient labeling methods should be used to
overcome this issue. We demonstrated that silica nano-
particles can be used as a reliable long-term tracking
agent in autofluorescent tissues. Thus, we believe that
this labeling method can track transplanted cells for
extended periods in other autofluorescent tissues (e.g.,
liver, and pancreas).
We used an invasive method of injecting directly into
the renal cortex after celiotomy to infuse stem cells into
the kidney. After the abdominal incision surgery, the
mice recovered immediately and gained weight normally,
and no other complications were observed. Abdominal
incisions can mobilize leukocytes and neutrophils to sur-
gical areas, which is usually normalized within 7 days. In
addition, we administrated broad-spectrum antibiotics to
prevent infection from the surgery. Therefore, we believe
that the effect of surgery on the mice and transplanted
MSCs was insignificant. Renal tissues exhibited mechan-
ical damage as shown by hemorrhaging and mild necro-
sis after the injection. The injury site may have been
exposed to a number of inflammatory cytokines and
chemokines owing to tissue inflammation. This micro-
environment may be activated to enhance the homing of
stem cells to these sites [27]. In the case of systemic
MSC infusion, although some transplanted cells are
located in the pathogenic area, most cells are trapped in
the liver or enter systemic circulation [25]. In contrast,
the detection rate of MSCs following intra-renal injec-
tion is much higher (20–50%) than that following sys-
temic injection [28]. Thus, we chose direct renal
injection to avoid systemic circulation of labeled MSCs,
and most MSCs were observed in the corticomedullary
junction and the medullary region at 2 or 3 weeks after
injection (Figure 6). The medullary region consists of
the proximal and distal tubules and the loop of Henle, in
which the main functions involve regulation of water
and electrolyte reabsorption. We presume that MSCs
gradually moved to the damaged tubular regions and
participated in tissue reconstitution. This relationship
between MSC migration and their therapeutic effect
needs further investigation. In any case, we expect thatsilica nanoparticle labeling will help elucidate the distri-
bution and fate of transplanted MSCs.
Frangioni et al. [29] reported the following criteria to
show that an ideal agent for tracking stem cells must (1)
be biocompatible and safe; (2) not require any genetic
modification or perturbation of the stem cells; (3) permit
single cell detection in any anatomical location; (4) allow
quantification of cell number; (5) have minimal or no di-
lution following cell division; (6) have minimal or no
transfer to non-stem cells; (7) permit non-invasive im-
aging in the living subject over months to years; and (8)
require no injectable contrast agent for visualization.
Our study demonstrated that silica nanoparticles satis-
fied most of these criteria. However, we used only one
cell line each for UCBMSCs and ATMSCs. Multiple cell
lines will need to be tested with silica nanoparticles be-
cause of possible differences among cell lines. Based on
our study, we suggest that silica nanoparticles represent
a viable approach for labeling and tracking of MSCs.
Conclusions
Our data demonstrate that silica nanoparticles uniformly
and completely label canine MSCs in a biocompatible
manner, resulting in unambiguous imaging with long-
term persistence, even in highly autofluorescent tissues.
Fluorescent silica nanoparticles are useful for labeling
cells and may help identify the molecular mechanisms of




BALB/c mice were purchased from Samtaco Bio Korea
Co., Ltd. (Osan, Korea). Six-week-old male mice (27–
33 g) were used in this study. All procedures involving
mice were approved and followed the regulations of the
Institutes of Laboratory Animals Resources (SNU-
120523-2, Seoul National University, Seoul, Korea).
Fluorescent silica nanoparticles
Fluorescent silica nanoparticles (NEO-STEM TSR50)
were purchased from Biterials Co., Ltd. (Seoul, Korea).
Silica nanoparticles were 50 nm in size and contained
RITC conjugated to terminal silanol groups.
Cell preparation
UCBMSCs were provided by the Adult Stem Cell Re-
search Center of Seoul National University (Seoul,
Korea). The isolation method and characterization of ca-
nine UCBMSCs have been described previously [18]. Ca-
nine ATMSCs were obtained from RNL Bio (Seoul,
Korea). Both types of canine MSCs were cultured in
low-glucose Dulbecco's Modified Eagle Medium
(DMEM; Gibco, Grand Island, NY, USA) supplemented
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tained at 37°C with 5% CO2 in a humidified incubator.
The medium was replaced every 3 days.
Labeling of canine MSCs with silica nanoparticles
Passage 3 ATMSCs and UCBMSCs were cultured to
90% confluency. Then, fluorescent silica nanoparticles
were added to the medium. To optimize the effective
concentration and incubation time for labeling, canine
MSCs were incubated for different time periods (2, 4
and 6 h) with various nanoparticle concentrations (100,
200 and 400 μg/ml). After incubation, the medium was
replaced with fresh medium.
To prepare silica nanoparticle-labeled MSCs for
transplantation, cells were incubated in nanoparticle-
containing medium for 24 h. Cells (2 × 105) were
suspended in normal saline for injection into the kidney.
Viability and proliferation of silica nanoparticle-labeled
MSCs
Cell proliferation and viability were evaluated by a WST-
1 assay and trypan blue exclusion. Cells were seeded in
96-well plates at 2 × 104 cells/well. After 24 h, nanoparti-
cles were added to the wells (0, 100, 200 or 400 μg/ml)
to a final volume of 100 μl. Each concentration was
assayed in triplicate, including the control wells. Cells
were then incubated for 24 h with silica nanoparticles,
and then 10 μl WST-1 reagent was added to each well.
The reaction proceeded for 2 h at 37°C with 5% CO2.
The absorbance of the samples at 450 nm was measured
by a microplate reader. Cell viability (%) relative to con-
trol wells without nanoparticles was calculated by [ab-
sorbance]test /[absorbance]control × 100.
For trypan blue exclusion, canine UCBMSCs and
ATMSCs were seeded into six-well culture plates and
then incubated at 37°C with 5% CO2. After 24 h, MSCs
were incubated with silica nanoparticles at 100, 200, 300
or 400 μg/ml for 6, 12, 24 and 36 h. Cells were then col-
lected and stained with a 0.4% trypan blue solution. Enu-
meration of viable cells was carried out under a light
microscope with a hemocytometer.
Mesenchymal lineage differentiation assays of canine
MSCs labeled with silica nanoparticles
Approximately 80% confluent canine MSCs at passage 2
in six-well plates were induced to differentiate into adi-
pocytes or osteocytes for 21 days in adipogenic or osteo-
genic media, respectively.
MSCs were treated with adipogenic medium for
21 days to induce adipogenic differentiation. Adipogenic
medium consisted of low-glucose DMEM containing
0.5 mM isobutyl methylxanthine (Sigma, St. Louis, MO,
USA), 10 μM insulin (Sigma), 200 μM indomethacin
(Sigma), 100 IU/ml penicillin, 100 μg/ml streptomycinand 20% FBS. The medium was changed three times a
week. Oil red O staining was conducted to indentify
lipid droplets.
MSCs were treated with osteogenic medium for
21 days to induce osteogenic differentiation. The osteo-
genic medium consisted of low-glucose DMEM contain-
ing 0.1 μM dexamethasone(Sigma), 10 mM β-glycerol
phosphate (Sigma), 0.2 mM ascorbic acid (Sigma),
100 IU/ml penicillin, 100 μg/ml streptomycin and 20%
FBS. The medium was changed three times a week. Ali-
zarin red S staining (Sigma) was conducted to assess
mineralized matrix content.
Transplantation of silica nanoparticle-labeled canine MSCs
into kidneys
We chose direct renal injection to determine whether
silica nanoparticle-labeled canine MSCs could be easily
detected in highly autofluorescent tissue. Male BALB/c
mice were randomly divided into two groups, the nor-
mal saline-injected group (n = 3), and the nanoparticle-
labeled canine MSC-injected group (n = 3). Under
anesthesia following an intramuscular injection of Zole-
tile 50 (40 mg/kg, Virbac Laboratories, Carros, France),
an abdominal incision was made, and the kidneys were
exposed. ATMSCs were then injected into the kidneys.
Cephalosporin (22 mg/kg) was injected intraperitoneally
to prevent infection resulting from the surgery. Mice
were sacrificed at 2 or 3 weeks after MSC
transplantation.
Tissue sample preparation
The kidneys were removed to examine the localization
of injected MSCs. Kidney samples were embedded in
OCT compound (Sakura Finetec USA Inc., Torrance,
CA, USA) for cryosectioning (4 μm thick) and then
examined by confocal laser scanning microscopy. Some
specimens were stained with DAPI to visualize the nu-
clei. One MSC-injected kidney was 4% (v/v) formalin-
fixed and paraffin-embedded, and then 4-μm-thick sec-
tions were processed for histology by hematoxylin and
eosin (H&E) staining.
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